Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.
Dang NH, Pro B, Hagemeister FB, Samaniego F, Jones D, Samuels BI, Rodriguez MA, Goy A, Romaguera JE, McLaughlin P, Tong AT, Turturro F, Walker PL, Fayad L.
Dang NH, et al. Among authors: fayad l.
Br J Haematol. 2007 Feb;136(3):439-47. doi: 10.1111/j.1365-2141.2006.06457.x.
Br J Haematol. 2007.
PMID: 17233846
Free article.
Clinical Trial.